Is Axogen Inc (AXGN) overvalued? · rev $187.3M
Axogen Inc (AXGN) is a medical devices company listed on US.
This page asks whether Axogen Inc (AXGN) looks expensive on cached numbers — not a short thesis.
Latest reported AXGN revenue for 2024-12-31 was $187.3M. Net income was -$10.0M. Revenue was up 17.8% from 2023-12-31 to 2024-12-31. AXGN currently screens at market cap $497.8M.
AXGN currently screens at market cap $497.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AXGN 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AXGN stock page for the full model, not this heading.
Not investment advice.